AusPAR: Saphnelo

Australian Public Assessment Report

AusPAR

AusPAR: Saphnelo [PDF, 1.21 MB]

AusPAR: Saphnelo [Word, 1.99 MB]

AusPAR Attachment 1: Product Information for Saphnelo [PDF, 313.55 KB]

AusPAR Attachment 1: Product Information for Saphnelo [Word, 203.2 KB]

Device/Product Name

Saphnelo

Active ingredients

Anifrolumab

AusPAR Date

6 December 2022

Published

15 December 2022

Submission Number

PM-2020-06383-1-2

Submission Type

New biological entity

Decision

Approved